No abstract available
Keywords:
GLP-1 recepter agonist; SGLT 2 inhibitor; astrgaloside IV; diabetes mellitus; huangkui capsule; ophiocordyceps sinensis; oxidative stress; pathomechanisms.
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.